Invited Commentary: Should We Be Doing Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma?
Authors:
- 13 February 2026
- journal article
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 242 (3) , 512-514
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell CarcinomaJournal of the American College of Surgeons, 2026
- Sentinel lymph node biopsy versus observation in high risk cutaneous squamous cell carcinoma of head and neck: a propensity score matching analysisArchives of Dermatological Research, 2024
- Adjuvant radiation following clear margin resection of high T-stage cutaneous squamous cell carcinoma halves the risk of local and locoregional recurrence: A dual-center retrospective studyJournal of the American Academy of Dermatology, 2022
- Pembrolizumab Monotherapy for Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Arm Phase II Trial (KEYNOTE-629)Journal of Clinical Oncology, 2020
- Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trialThe Lancet Oncology, 2020
- Cutaneous Squamous Cell CarcinomaHematology/Oncology Clinics of North America, 2019
- Practical Guide to Surgical Data Sets: National Cancer Database (NCDB)JAMA Surgery, 2018
- Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma on the Head and NeckJAMA Otolaryngology–Head & Neck Surgery, 2016
- Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guidelineEuropean Journal of Cancer, 2015
- Cancer Recurrence: An Important but Missing Variable in National Cancer RegistriesAnnals of Surgical Oncology, 2014